ijms-logo

Journal Browser

Journal Browser

Drug Discovery: Using Zebrafish and Medaka

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".

Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 2299

Special Issue Editors


E-Mail Website
Guest Editor
Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani, Toyama 930-0194, Japan
Interests: zebrafish; drug discovery; brain disease; neurodegenerative diseases; stroke; Alzheimer’s disease

E-Mail Website
Guest Editor
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8563, Japan
Interests: medaka; genetic engineering; live imaging; drug discovery; disease model; nervous system; lymphatic vasculature

Special Issue Information

Dear Colleagues,

Although zebrafish and medaka are vertebrates, their embryos are transparent, their breeding is easy, their life cycle is short, and it is easy to create mutations and genetically modified animals. These approaches are used in research on biological control such as development and regeneration. In recent years, the spirit of animal welfare has increased demand as an alternative to mammalian models.

Recently, disease model research using zebrafish and medaka, basic research with a view to drug discovery, pharmacological action, and compound screening research are increasing and attracting more and more attention. Expectations are also growing around fish models as an evaluation system for animal experiments to replace mammals, not only in the development of pharmaceuticals, but also in the development of cosmetics, foods and supplements, and in environmental surveys.

In this Special Issue, we invite the submission of research on disease models and toxicity tests aimed at drug discovery using fish such as zebrafish and medaka.

Dr. Toshiaki Kume
Dr. Tomonori Deguchi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • zebrafish
  • medaka
  • drug discovery
  • live imaging
  • drug screening
  • disease model

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 2959 KiB  
Article
Small-Molecule-Mediated Suppression of BMP Signaling by Selective Inhibition of BMP1-Dependent Chordin Cleavage
by Takamasa Mizoguchi, Shohei Mikami, Mari Yatou, Yui Kondo, Shuhei Omaru, Shuhei Kuwabara, Wataru Okura, Syouta Noda, Takeshi Tenno, Hidekazu Hiroaki and Motoyuki Itoh
Int. J. Mol. Sci. 2023, 24(5), 4313; https://doi.org/10.3390/ijms24054313 - 21 Feb 2023
Viewed by 1935
Abstract
BMP signaling is critical for many biological processes. Therefore, small molecules that modulate BMP signaling are useful for elucidating the function of BMP signaling and treating BMP signaling-related diseases. Here, we performed a phenotypic screening in zebrafish to examine the in vivo effects [...] Read more.
BMP signaling is critical for many biological processes. Therefore, small molecules that modulate BMP signaling are useful for elucidating the function of BMP signaling and treating BMP signaling-related diseases. Here, we performed a phenotypic screening in zebrafish to examine the in vivo effects of N-substituted-2-amino-benzoic acid analogs NPL1010 and NPL3008 and found that they affect BMP signaling-dependent dorsal–ventral (D–V) patterning and bone formation in zebrafish embryos. Furthermore, NPL1010 and NPL3008 suppressed BMP signaling upstream of BMP receptors. BMP1 cleaves Chordin, an antagonist of BMP, and negatively regulates BMP signaling. Docking simulations demonstrated that NPL1010 and NPL3008 bind BMP1. We found that NPL1010 and NPL3008 partially rescued the disruptions in the D–V phenotype caused by bmp1 overexpression and selectively inhibited BMP1-dependent Chordin cleavage. Therefore, NPL1010 and NPL3008 are potentially valuable inhibitors of BMP signaling that act through selective inhibition of Chordin cleavage. Full article
(This article belongs to the Special Issue Drug Discovery: Using Zebrafish and Medaka)
Show Figures

Figure 1

Back to TopTop